Cours Inspyr Therapeutics, Inc. Other OTC
Actions
NSPX
US45782A4031
Recherche biotechnologique et médicale
CA 2021 | - | CA 2022 | - | Capitalisation | 241 k 216 k |
---|---|---|---|---|---|
Résultat net 2021 | 2 M 1,79 M | Résultat net 2022 | -1 M -896 k | VE / CA 2021 | - |
Trésorerie nette 2021 | 197 k 176 k | Dette nette 2022 | 305 k 273 k | VE / CA 2022 | - |
PER 2021 |
-0,4
x | PER 2022 |
-0,23
x | Employés | - |
Rendement 2021 * |
-
| Rendement 2022 |
-
| Flottant | 100% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Silvestre Raul
CEO | Chief Executive Officer | 53 | - |
Michael Elliott
CTO | Chief Tech/Sci/R&D Officer | - | 11/10/16 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Scott Ogilvie
BRD | Director/Board Member | 69 | 01/02/08 |
Silvestre Raul
CEO | Chief Executive Officer | 53 | - |
Claire Thomas
BRD | Director/Board Member | 68 | 12/10/16 |
Varia. 1 janv. | Capi. | |
---|---|---|
+15,55% | 121 Md | |
+12,66% | 107 Md | |
-2,53% | 24,82 Md | |
+1,14% | 22,48 Md | |
-9,35% | 18,32 Md | |
-42,28% | 16,33 Md | |
-18,92% | 15,31 Md | |
+6,19% | 14,08 Md | |
+28,83% | 11,74 Md |